Quintian Pharma

Malta, United States Founded: 2015 • Age: 11 yrs Acquired By PQE Group
Provider of quality assurance, pharmacovigilance, and regulatory affair services

About Quintian Pharma

Quintian Pharma is a Healthcare company based in Malta (United States) founded in 2015, and was acquired by PQE Group in July 2022. Provider of quality assurance, pharmacovigilance, and regulatory affair services. Quintian Pharma offers products and services including EU GMP Certification, EU Batch Testing and Release, Pharmacovigilance, and EU-CTD Registration. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its competitors include Indegene, IntegriChain and ClearView Healthcare Partners; 2 of its 3 listed competitors have raised funding.

Company details

Quintian Pharma was established in 2015 as a provider of services in the pharmaceutical sector. Operations are focused on quality assurance, pharmacovigilance, and regulatory affairs, supporting compliance and safety in drug development. The company maintains locations in Malta and the United States, serving clients across international markets with specialized consulting and monitoring solutions.

  • Headquarters Malta, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website quintianpharma.com
  • Social LinkedIn
  • Acquired by PQE Group (Jul 2022)
Key Metrics

Products & Services of Quintian Pharma

Quintian Pharma offers a comprehensive portfolio of products and services, including EU GMP Certification, EU Batch Testing and Release, Pharmacovigilance, and EU-CTD Registration.

EU GMP Certification
Certification Services

Service for certifying pharmaceutical manufacturing sites to EU standards

EU Batch Testing and Release
Testing Services

Analysis and certification of pharmaceutical batches for market release

Pharmacovigilance
Monitoring Services

Post-marketing surveillance of pharmaceutical products for safety

EU-CTD Registration
Regulatory Services

Compilation and submission of regulatory dossiers for EU approval

Investors in Quintian Pharma

Quintian Pharma has secured backing from 1 investor. Prominent investors backing the company include PQE Group.

All
InvestorDescriptionFounded YearDomainLocation
Offers regulatory affairs, auditing, and compliance services to businesses.
1998pqegroup.comFlorence, Italy
Premium access

Investor details for Quintian Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Quintian Pharma

1 people are tracked at Quintian Pharma (1 in leadership).

NameRoleGroup
Claude Vella Bonanno
Managing DirectorLeadership
Premium access

Complete people profiles for Quintian Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Quintian Pharma

2 dated milestones of Quintian Pharma across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Quintian Pharma is founded.
  2. Exit Acquired by PQE Group.

Competitors of Quintian Pharma

Quintian Pharma has 3 listed competitors in our database, 2 of them funded. They include Indegene, IntegriChain and ClearView Healthcare Partners.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indegene.com1998Princeton, United States$220M350
Suite solutions are provided for payers and healthcare providers.
integrichain.com2005Philadelphia, United States$2M320
Inventory, order and customer relationship management solution for life science suppliers.
clearviewhcp.com2008Newton, United States381
Strategic consulting services are provided to life sciences companies.
Premium access

Detailed competitors of Quintian Pharma

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Quintian Pharma

The website of Quintian Pharma (quintianpharma.com) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

    ▲ 289.3% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Quintian Pharma (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Quintian Pharma

Premium access

Complete news archive for Quintian Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Quintian Pharma

Quintian Pharma was founded in 2015.

Quintian Pharma is headquartered in Malta, United States. It is registered at Malta, Ohio, United States.

Quintian Pharma was established in 2015 as a provider of services in the pharmaceutical sector. Operations are focused on quality assurance, pharmacovigilance, and regulatory affairs, supporting compliance and safety in drug development. The company maintains locations in Malta and the United States, serving clients across international markets with specialized consulting and monitoring solutions.

Quintian Pharma's top competitors include Indegene, IntegriChain and ClearView Healthcare Partners.

Quintian Pharma offers EU GMP Certification, EU Batch Testing and Release, Pharmacovigilance, and EU-CTD Registration.

Quintian Pharma has 1 investor. Key investors include PQE Group.

Yes. Quintian Pharma was acquired by PQE Group in July 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available